ANIK Earnings
Latest Revenue32.6M
Latest Net Income3.3M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.25 | 32.6M | 3.3M | +15.6% | +189.3% |
| Q1 2026 | -$0.37 | 29.6M | -5056000 | +13.2% | -8.8% |
| Q4 2025 | $0.02 | 30.6M | 292.0K | +0.0% | +101.3% |
| Q3 2025 | -$0.16 | 27.8M | -2329000 | -5.9% | +92.1% |
| Q2 2025 | -$0.28 | 28.2M | -3970000 | -8.2% | -2,700.0% |
| Q1 2025 | -$0.34 | 26.2M | -4873000 | -9.8% | -9.7% |
| Q4 2024 | -$1.50 | 30.6M | -21865000 | -28.8% | +65.1% |
| Q3 2024 | -$2.03 | 29.6M | -29918000 | -28.7% | -351.1% |
| Q2 2024 | -$0.01 | 30.7M | -88000 | — | — |
| Q1 2024 | -$0.31 | 29.0M | -4514000 | — | — |
| Q4 2023 | -$4.30 | 43.0M | -63000000 | — | — |
| Q3 2023 | -$0.45 | 41.5M | -6576000 | — | — |
Anika Therapeutics (ANIK) — Earnings